Adjuvance Technologies Inc.: Adjuvance Technologies Announces Issuance of U.S. Patent Covering Semi-Synthetic Saponin Adjuvants
Patent Covers TQL-1055 Adjuvant for Multiple Uses, Including Shingles Vaccine Protects the Foundation of the Company's Proprietary Adjuvant Technology Adjuvance Technologies Inc., a privately-held
United States Kostenloser Wertpapierhandel Howard Matzner Tyler Martin National Institutes Of Health Foundation Of The Company Proprietary Adjuvant Technology
Source: finanznachrichten.de